Literature DB >> 19221506

Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability.

Jianyong Xiao1, Zhiyi Zhang, George Gong Chen, Meifang Zhang, Yuanjie Ding, Jia Fu, Mingtao Li, Jing-Ping Yun.   

Abstract

The cyclin-dependent kinase inhibitor p21(WAF1/CIP1) is a critical regulator of cell cycle, and it is easily degraded by proteasome through ubiquitin-dependent and -independent pathway. The mechanism of the post-translational regulation of p21 stability remains to be further clarified. In the present study, we have identified nucleophosmin (NPM)/B23, a multifunctional protein that bound p21 and contributed to its stability. The direct interaction between p21 and NPM was confirmed by reciprocal co-immunoprecipitation and GST pull-down assay. Confocal microscopy showed that NPM partially co-localized with p21 in nucleoplasm and their co-localization increased treated with Act D which induces the nucleoplasmic translocation of NPM. We observed the half life of p21 was prolonged with overexpression of NPM or Act D treatment. Knockdown of NPM by siRNA resulted in downregulation of p21 and impaired upregulation of p21 treated with Act D. Further, we examined the effect of NPM expression on the ubiquitination of p21. Overexpression of NPM inhibited the ubiquitination of p21, and depletion of NPM remarkably improved the ubiquitination of p21. Altogether, we provide evidence for a direct binding between NPM and p21, and assign NPM as a positive post-translational regulator of p21.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221506     DOI: 10.4161/cc.8.6.7898

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Authors:  Narasimharao Nalabothula; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

Review 2.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

3.  FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Authors:  Updesh Dixit; Ashutosh K Pandey; Zhihe Liu; Sushil Kumar; Matthew B Neiditch; Kenneth M Klein; Virendra N Pandey
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.

Authors:  Chris Z Y Zhang; George G Chen; Juanita L Merchant; Paul B S Lai
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

5.  The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.

Authors:  Aishwarya G Jacob; Ravi K Singh; Fuad Mohammad; Thomas W Bebee; Dawn S Chandler
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

Review 6.  Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Cycle       Date:  2010-06-15       Impact factor: 4.534

7.  Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon Bonegio; Andrea Havasi; Katarina Illanes; John H Schwartz; Steven C Borkan
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

8.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

9.  Role of far upstream element binding protein 1 in colonic epithelial disruption during dextran sulphate sodium-induced murine colitis.

Authors:  Qiyun Tang; Weiwei Xia; Qianqian Ji; Runzhou Ni; Jian'an Bai; Liren Li; Yongwei Qin
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 10.  Far upstream element binding protein 1: a commander of transcription, translation and beyond.

Authors:  J Zhang; Q M Chen
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.